A Fluorogenic Probe Based On Chelation-Hydrolysis-Enhancement Mechanism For Visualizing Zn2+ In Parkinson'S Disease Models
Gaobin Zhang,Yanfei Zhao,Bo Peng,Zheng Li,Chenchen Xu,Yi Liu,Chengwu Zhang,Nicolas H. Voelcker,Lin Li,Wei Huang
DOI: https://doi.org/10.1039/c8tb03343a
IF: 7.571
2019-01-01
Journal of Materials Chemistry B
Abstract:Developing efficient methods for the real-time detection of Zn2+ levels in biological systems is highly relevant to improving our understanding of the role of Zn2+ in the progression of Parkinson's disease (PD). In this work, a novel Schiff base based Zn2+ fluorescent probe (ZP) was designed, synthesized and systematically investigated. A significant turn-on effect on ZP upon the addition of Zn2+ was observed, accompanied by a blue-shift of the fluorescence spectra. ZP is sensitive to Zn2+ and has excellent selectivity against various biologically relevant cations, anions and amino acids. The sensing mechanism of ZP was studied by H-1 NMR, MS, single crystal X-ray diffraction and theoretical calculations. The results showed that the response of ZP to Zn2+ was based on the chelation-hydrolysis-enhancement process. Upon bonding, Zn2+ hydrolyzes the Schiff base to an aldehyde precursor, the resulting aldehyde further coordinates to Zn2+ to form a more stable heterobimetallic complex leading to the emission enhancement and blue-shift. ZP was applied to imaging exogenous/endogenous Zn2+ in live HeLa cells. Furthermore, we successfully measured the Zn2+ levels using in vitro PD models, which provided a visualization method to better understand the relationship between Zn2+ levels and PD development.